|
KLHL28 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.512100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.337300E-03 |
| Normal-vs-Stage2 |
2.632800E-01 |
| Normal-vs-Stage3 |
2.631600E-01 |
| Normal-vs-Stage4 |
1.211750E-01 |
| Stage1-vs-Stage2 |
4.921800E-01 |
| Stage1-vs-Stage3 |
5.990400E-01 |
| Stage1-vs-Stage4 |
9.293200E-01 |
| Stage2-vs-Stage3 |
8.808400E-01 |
| Stage2-vs-Stage4 |
6.826800E-01 |
| Stage3-vs-Stage4 |
8.324600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.645500E-02 |
| Normal-vs-AfricanAmerican |
4.918300E-02 |
| Normal-vs-Asian |
9.156300E-02 |
| Caucasian-vs-AfricanAmerican |
9.382000E-01 |
| Caucasian-vs-Asian |
7.268000E-01 |
| AfricanAmerican-vs-Asian |
6.945800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.344230E-02 |
| Normal-vs-Female |
5.290400E-01 |
| Male-vs-Female |
1.242850E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.522800E-03 |
| Normal-vs-Extreme_Weight |
1.680470E-03 |
| Normal-vs-Obese |
4.832600E-01 |
| Normal-vs-Extreme_Obese |
9.818000E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.107600E-01 |
| Normal_Weight-vs-Obese |
9.695500E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.433000E-01 |
| Extreme_Weight-vs-Obese |
3.798500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.966200E-01 |
| Obese-vs-Extreme_Obese |
4.460600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.029600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.141000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.615420E-03 |
| Normal-vs-Age(81-100Yrs) |
1.181430E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.001600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.062790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.342100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.410070E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.071880E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.048800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.940500E-02 |
| Normal-VS-Type2 PRCC |
3.401300E-04 |
| Normal-VS-KIRP CIMP |
6.576200E-01 |
| Normal-VS-Unclassified PRCC |
9.797000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.094360E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.644600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.914800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.642370E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.750500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.192400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.791600E-04 |
| Normal-vs-N1 |
6.932000E-01 |
| Normal-vs-N2 |
1.693550E-02 |
| N0-vs-N1 |
1.170770E-01 |
| N0-vs-N2 |
4.726800E-01 |
| N1-vs-N2 |
2.722800E-01 |
|
|
